Considerable progress has been made in improving the tolerability of antidepressant drugs. The classical tricyclic antidepressants (TCA) are still, however, the standard for ecacy. The selective serotonin reuptake inhibitors are better tolerated that the tricyclics, but their ecacy in major depressi
Milnacipran: The Clinical Properties of a Selective Serotonin and Noradrenaline Reuptake Inhibitor (SNRI)
โ Scribed by Y. Lecrubier
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 134 KB
- Volume
- 12
- Category
- Article
- ISSN
- 0885-6222
No coin nor oath required. For personal study only.
โฆ Synopsis
Milnacipran is a novel antidepressant agent which selectively inhibits the reuptake of serotonin and noradrenaline without directly aecting postsynaptic receptor sites. The biochemical and pharmacological proยฎle of milnacipran suggested that the drug would be therapeutically eective and well tolerated. This has been borne out by the results of placebo-controlled and open label trials of the antidepressant ecacy of milnacipran, as well as of comparative trials with tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs). The designs and results of these studies are reviewed in this paper.
Milnacipran is more eective than placebo in the treatment of major depressive episodes. It is equally eective as TCAs, but better tolerated. Milnacipran appears to be superior in ecacy to the SSRIs, particularly in patients with severe depression, and is equally well tolerated.
The ecacy and tolerance proยฎle of milnacipran reยฏects its speciยฎc pharmacological activity. The eects of milnacipran are conยฎned to the inhibition of serotonin and noradrenaline reuptake. There is no activity on postsynaptic receptors. Overall, milnacipran oers a beneยฎcial combination of good ecacy and tolerability in patients with major depression.
๐ SIMILAR VOLUMES
There are accumulating reports of withdrawal symptoms emerging following the discontinuation of selective serotonin reuptake inhibitor antidepressants. This report summarizes published reports, characterizes the withdrawal syndrome, discusses potential mechanisms of withdrawal, and makes recommendat
Antidepressant treatment may be desirable or necessary during pregnancy; however, the beneยฎt of treatment must balance the beneยฎts to the mother with any risk to the developing fetus. In order to make educated, patient-speciยฎc, beneยฎt-to-risk assessments, an understanding of possible risks associate
This retrospective chart review examines the impact of selective serotonin reuptake inhibitors on 20 patients with both depression and psychosis complicating dementia of the Alzheimer type (DAT) and other dementias. Fifteen of the 20 patients had moderate to marked improvement in depressive and psyc
Canine acral lick dermatitis (ALD) has been suggested as an animal analogue of obsessive-compulsive disorder (OCD). A series of dogs with ALD or similar conditions were treated with citalopram, the most selective of the selective serotonin reuptake inhibitors. Six of nine (66.7%) dogs showed signifi